Bridge to Seed
Myria Biosciences is building a platform that uses AI & engineered microbes to create new natural-product-inspired molecules for medicine, unlocking a vast new chemical space for drug discovery.
We have acheived early industry traction and are raising a small bridge ahead of seed to complete two key proof points for pharma partners and our proprietary asset pipeline.
Get in touch to learn more:
Steven Schmitt, CEO
+41 61 551 03 80
steven.schmitt@myria.bio
More information